- Article
Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines
- Gina Abdelaal,
- Andrew Carter,
- William Cheung,
- Mihalis Panayiotidis,
- Seth Racey,
- David Tétard and
- Stephany Veuger
Anti-cancer therapy by iron chelation has been shown to inhibit many cellular processes including DNA replication, mitochondrial metabolism and oncogenic signalling pathways (e.g., EGFR). Iron chelator SK4 represents a double pronged approach towards...